These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
469 related articles for article (PubMed ID: 34551665)
1. Brigatinib loaded poly(d,l-lactide-co-glycolide) nanoparticles for improved anti-tumoral activity against non-small cell lung cancer cell lines. Ahmed MM; Fatima F; Anwer MK; Aldawsari MF; Bhatia S; Al-Harrasi A Drug Dev Ind Pharm; 2021 Jul; 47(7):1112-1120. PubMed ID: 34551665 [TBL] [Abstract][Full Text] [Related]
2. Development and characterization of Brigatinib loaded solid lipid nanoparticles: In-vitro cytotoxicity against human carcinoma A549 lung cell lines. Ahmed MM; Fatima F; Anwer MK; Aldawsari MF; Alsaidan YSM; Alfaiz SA; Haque A; Az A; Alhazzani K Chem Phys Lipids; 2020 Nov; 233():105003. PubMed ID: 33096096 [TBL] [Abstract][Full Text] [Related]
3. Effect of Solvents, Stabilizers and the Concentration of Stabilizers on the Physical Properties of Poly(d,l-lactide- Alkholief M; Kalam MA; Anwer MK; Alshamsan A Pharmaceutics; 2022 Apr; 14(4):. PubMed ID: 35456705 [TBL] [Abstract][Full Text] [Related]
4. Sonication tailored enhance cytotoxicity of naringenin nanoparticle in pancreatic cancer: design, optimization, and Akhter MH; Kumar S; Nomani S Drug Dev Ind Pharm; 2020 Apr; 46(4):659-672. PubMed ID: 32208984 [No Abstract] [Full Text] [Related]
5. Effect of a 2-HP-β-Cyclodextrin Formulation on the Biological Transport and Delivery of Chemotherapeutic PLGA Nanoparticles. Zheng K; Huang Z; Huang J; Liu X; Ban J; Huang X; Luo H; Chen Z; Xie Q; Chen Y; Lu Z Drug Des Devel Ther; 2021; 15():2605-2618. PubMed ID: 34168432 [TBL] [Abstract][Full Text] [Related]
7. Preparation and characterization of surface-modified PLGA-polymeric nanoparticles used to target treatment of intestinal cancer. Ahmad N; Alam MA; Ahmad R; Naqvi AA; Ahmad FJ Artif Cells Nanomed Biotechnol; 2018 Mar; 46(2):432-446. PubMed ID: 28503995 [TBL] [Abstract][Full Text] [Related]
8. Carboplatin loaded Surface modified PLGA nanoparticles: Optimization, characterization, and in vivo brain targeting studies. Jose S; Juna BC; Cinu TA; Jyoti H; Aleykutty NA Colloids Surf B Biointerfaces; 2016 Jun; 142():307-314. PubMed ID: 26970818 [TBL] [Abstract][Full Text] [Related]
9. In vitro-in vivo evaluation of chitosan-PLGA nanoparticles for potentiated gastric retention and anti-ulcer activity of diosmin. Abd El Hady WE; Mohamed EA; Soliman OAE; El-Sabbagh HM Int J Nanomedicine; 2019; 14():7191-7213. PubMed ID: 31564873 [TBL] [Abstract][Full Text] [Related]
10. In vitro degradation of poly (D, L-lactide-co-glycolide) nanoparticles loaded with linamarin. Hussein AS; Abdullah N; Ahmadun FR IET Nanobiotechnol; 2013 Jun; 7(2):33-41. PubMed ID: 24046903 [TBL] [Abstract][Full Text] [Related]
11. Development of bicalutamide-loaded PLGA nanoparticles: preparation, characterization and in-vitro evaluation for the treatment of prostate cancer. Ray S; Ghosh Ray S; Mandal S Artif Cells Nanomed Biotechnol; 2017 Aug; 45(5):944-954. PubMed ID: 27327352 [TBL] [Abstract][Full Text] [Related]
12. Preparation and in vitro characterization of 9-nitrocamptothecin-loaded long circulating nanoparticles for delivery in cancer patients. Derakhshandeh K; Soheili M; Dadashzadeh S; Saghiri R Int J Nanomedicine; 2010 Aug; 5():463-71. PubMed ID: 20957168 [TBL] [Abstract][Full Text] [Related]
13. Preparation and Evaluation of Irinotecan Poly(Lactic-co-Glycolic Acid) Nanoparticles for Enhanced Anti-tumor Therapy. Yang X; Yang Y; Jia Q; Hao Y; Liu J; Huang G AAPS PharmSciTech; 2019 Feb; 20(3):133. PubMed ID: 30820689 [TBL] [Abstract][Full Text] [Related]
14. Preparation, evaluation, and Pan X; Liu S; Ju L; Xi J; He R; Zhao Y; Zhuang R; Huang J Drug Dev Ind Pharm; 2020 Nov; 46(11):1889-1897. PubMed ID: 32975456 [TBL] [Abstract][Full Text] [Related]
15. Formulation and Evaluation of Pravastatin Sodium-Loaded PLGA Nanoparticles: In vitro-in vivo Studies Assessment. Elsayed SI; Girgis GNS; El-Dahan MS Int J Nanomedicine; 2023; 18():721-742. PubMed ID: 36816332 [TBL] [Abstract][Full Text] [Related]
16. Improved mucoadhesion and cell uptake of chitosan and chitosan oligosaccharide surface-modified polymer nanoparticles for mucosal delivery of proteins. Dyawanapelly S; Koli U; Dharamdasani V; Jain R; Dandekar P Drug Deliv Transl Res; 2016 Aug; 6(4):365-79. PubMed ID: 27106502 [TBL] [Abstract][Full Text] [Related]
17. Celecoxib-loaded poly(D,L-lactide-co-glycolide) nanoparticles prepared using a novel and controllable combination of diffusion and emulsification steps as part of the salting-out procedure. McCarron PA; Donnelly RF; Marouf W J Microencapsul; 2006 Aug; 23(5):480-98. PubMed ID: 16980271 [TBL] [Abstract][Full Text] [Related]
18. Calcium hydroxide-loaded PLGA biodegradable nanoparticles as an intracanal medicament. Elmsmari F; González Sánchez JA; Duran-Sindreu F; Belkadi R; Espina M; García ML; Sánchez-López E Int Endod J; 2021 Nov; 54(11):2086-2098. PubMed ID: 34355406 [TBL] [Abstract][Full Text] [Related]
19. Doxorubicin-loaded star-shaped copolymer PLGA-vitamin E TPGS nanoparticles for lung cancer therapy. Zhang J; Tao W; Chen Y; Chang D; Wang T; Zhang X; Mei L; Zeng X; Huang L J Mater Sci Mater Med; 2015 Apr; 26(4):165. PubMed ID: 25791459 [TBL] [Abstract][Full Text] [Related]
20. Dual receptor specific nanoparticles targeting EGFR and PD-L1 for enhanced delivery of docetaxel in cancer therapy. Emami F; Duwa R; Banstola A; Woo SM; Kwon TK; Yook S Biomed Pharmacother; 2023 Sep; 165():115023. PubMed ID: 37329708 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]